KAEF

PT Kimia Farma Tbk, together with its subsidiaries, manufactures and sells a range of medicines in Indonesia and internationally. It operates through Manufacture, Distribution, Retail, and Others segments. The company offers drugs in the form of tablets, effervescent tablets, hard and soft capsules, liquids, syrups, oral powders, non-beta-lactam external liquids, beta-lactam tablets and dry syrups, injections, ointments, creams, suppositories, semisolid dosage forms, and health supplements; traditional medicines; generic drugs, such as paracetamol, amoxicillin, and omeprazole; ethical products; over-the-counter products and herbs; and narcotic drugs and psychotropics. It also provides health food; cosmetics; edible, castor, and essential oils; active pharmaceutical ingredients and high-function chemicals; quinine salt and its derivatives; antiseptic solutions; stem cells; and medical devices. In addition, the company engages in the provision of integrated health services, including pharmacies, health and beauty clinics, clinical and diagnostic laboratories, and optics; pharmacy retail management; and distribution of medicines to pharmacies, hospital pharmacies, medical centers, and drug stores, as well as cosmetics and medical devices. It exports its products to Asia, Europe, Australia, Africa, and America. The company was founded in 1817 and is headquartered in Jakarta Pusat, Indonesia. PT Kimia Farma Tbk operates as a subsidiary of PT. Bio Farma.